chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: urinary tract infection; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (urinary tract infection) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Prostate infection.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced URINARY TRACT INFECTION (urinary tract infection). The patient was treated with CIPROFLOXACIN for UTI, at a dose of 500 mg. At the time of the report, URINARY TRACT INFECTION (urinary tract infection) outcome was unknown. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medication were reported.     Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Follow up contains No new information
Sex: M
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: worse symptoms; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (worse symptoms) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (worse symptoms). At the time of the report, ADVERSE EVENT (worse symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Diffiulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Diffiulty breathing) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced DYSPNOEA (Diffiulty breathing). At the time of the report, DYSPNOEA (Diffiulty breathing) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed Dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed Dose) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed Dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed Dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient was hospitalized at the time he was supposed to receive the second dose. Caller states the hospitalization is not vaccine or COVID related. He was already a sick individual with a past medical history that resulted in hospitalization. Caller states the medical director advises on giving the second dose at this time. No further information provided as caller did not elaborate on the event as he did not feel it was vaccine related.  No concomitant medications were reported No treatment drugs were reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Feeling abnormal, Pain in extremity
Clinical narrative: felt no energy; wasn't feeling that great; felt so tired; soreness in left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in left arm), ASTHENIA (felt no energy), FEELING ABNORMAL (wasn't feeling that great) and FATIGUE (felt so tired) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No medical history was provided by reporter.  Concomitant products included HYDROCHLOROTHIAZIDE, METOPROLOL and METFORMIN for an unknown indication.    On 28-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (soreness in left arm). On 05-Apr-2021, the patient experienced ASTHENIA (felt no energy), FEELING ABNORMAL (wasn't feeling that great) and FATIGUE (felt so tired). At the time of the report, PAIN IN EXTREMITY (soreness in left arm), ASTHENIA (felt no energy), FEELING ABNORMAL (wasn't feeling that great) and FATIGUE (felt so tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications were not provided by reporter.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: hurt a bit in the same arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (hurt a bit in the same arm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included ATORVASTATIN, LORAZEPAM (ATIVAN), HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HCTZ), LOSARTAN, AMLODIPINE, ASA, OMEPRAZOLE, LEVOTHYROXINE SODIUM (SYNTHROID) and TADALAFIL (CIALIS) for an unknown indication.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced PAIN IN EXTREMITY (hurt a bit in the same arm). At the time of the report, PAIN IN EXTREMITY (hurt a bit in the same arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medications were reported .   This case was linked to MOD-2021-077869 (E2B Linked Report).; Sender's Comments:  MOD-2021-077869:First dose case
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077895 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077895:Cross-linked with second dose
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Gastrooesophageal reflux disease
Clinical narrative: experience reflux till today; This spontaneous case was reported by a physician and describes the occurrence of GASTROOESOPHAGEAL REFLUX DISEASE (experience reflux till today) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030A21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced GASTROOESOPHAGEAL REFLUX DISEASE (experience reflux till today). At the time of the report, GASTROOESOPHAGEAL REFLUX DISEASE (experience reflux till today) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by investigator
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: itching; real bad hives; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and URTICARIA (real bad hives) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching) and URTICARIA (real bad hives). At the time of the report, PRURITUS (itching) and URTICARIA (real bad hives) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.   This case was linked to MOD-2021-077830, US-MODERNATX, INC.-MOD-2021-116622 (Linked Report).; Sender's Comments:  MOD-2021-077830:same reporter US-MODERNATX, INC.-MOD-2021-116622:Case for neighbour
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain, Pain in extremity, Vision blurred
Clinical narrative: Arm pain (both arms); Blurry vision; Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain (both arms)), VISION BLURRED (Blurry vision), PAIN (Body aches) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain (both arms)), VISION BLURRED (Blurry vision), PAIN (Body aches) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Arm pain (both arms)), VISION BLURRED (Blurry vision), PAIN (Body aches) and HEADACHE (Headache) outcome was unknown.            No relevant concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.
Sex: F
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: sore arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced MYALGIA (sore arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, MYALGIA (sore arm) outcome was unknown. Not Provided          No relevant concomitant medications reported. After second dose HCP told her to take Ibuprofen if she needs it. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 16.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: A 16-year old male patient who received the first dose of vaccine; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16-year old male patient who received the first dose of vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16-year old male patient who received the first dose of vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (A 16-year old male patient who received the first dose of vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient's pre-existing medical condition include some kind of developmental disability.  No concomitant medications were reported. No treatment medication was reported.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Patient is beyond 42 days for second Moderna vaccine; This spontaneous case was reported by a physician and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is beyond 42 days for second Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is beyond 42 days for second Moderna vaccine). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient is beyond 42 days for second Moderna vaccine) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Vaccination site erythema, Vaccination site lymphadenopathy, Vaccination site pruritus
Clinical narrative: itchy injection site; red injection site; swollen lymph nodes on neck; swollen lymph nodes under injected arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itchy injection site), LYMPHADENOPATHY (swollen lymph nodes on neck), VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes under injected arm) and VACCINATION SITE ERYTHEMA (red injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No medical history reported.     On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes on neck) and VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes under injected arm). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy injection site) and VACCINATION SITE ERYTHEMA (red injection site). At the time of the report, VACCINATION SITE PRURITUS (itchy injection site), LYMPHADENOPATHY (swollen lymph nodes on neck), VACCINATION SITE LYMPHADENOPATHY (swollen lymph nodes under injected arm) and VACCINATION SITE ERYTHEMA (red injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.  Treatment information not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Body temperature abnormal, Malaise
Clinical narrative: Not feeling well all week after first vaccine; Unable to get warm with body temperature 94 and 95 degree; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well all week after first vaccine) and BODY TEMPERATURE ABNORMAL (Unable to get warm with body temperature 94 and 95 degree) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LISINOPRIL, SIMVASTATIN, PANTOPRAZOLE and SALBUTAMOL SULFATE (PROAIR DIGIHALER) for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MALAISE (Not feeling well all week after first vaccine) and BODY TEMPERATURE ABNORMAL (Unable to get warm with body temperature 94 and 95 degree). At the time of the report, MALAISE (Not feeling well all week after first vaccine) and BODY TEMPERATURE ABNORMAL (Unable to get warm with body temperature 94 and 95 degree) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, Body temperature: 94-95 degree (Inconclusive) 94-95 degree.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up received on 18-May-2021 included updated outcome of events to recovered. Patient declined to further follow up.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Injection site arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site arm was sore) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Injection site arm was sore). At the time of the report, VACCINATION SITE PAIN (Injection site arm was sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077602 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077602:Crosslinked with daughter's case (MOD21-076473)
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products, SARS-CoV-2 antibody test, Vaccination site pain
Clinical narrative: the first dose I received was Moderna and the second dose was Pfizer and no one ever told me; after both doses was tenderness at injection site.; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (the first dose I received was Moderna and the second dose was Pfizer and no one ever told me) and VACCINATION SITE PAIN (after both doses was tenderness at injection site.) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. EL9269) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (the first dose I received was Moderna and the second dose was Pfizer and no one ever told me) and VACCINATION SITE PAIN (after both doses was tenderness at injection site.). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (the first dose I received was Moderna and the second dose was Pfizer and no one ever told me) had resolved and VACCINATION SITE PAIN (after both doses was tenderness at injection site.) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Thyroid pills and Cholesterol pills.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity, Vision blurred
Clinical narrative: Blurry vision; Arm pain; Body aches; Headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (Blurry vision), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body aches) and HEADACHE (Headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041B21A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (Blurry vision), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body aches) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VISION BLURRED (Blurry vision), PAIN IN EXTREMITY (Arm pain), MYALGIA (Body aches) and HEADACHE (Headache) outcome was unknown.            Concomitants were not reported.   Reporter did not allow further contact
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Insomnia, Palpitations
Clinical narrative: Heart Palpitations; Heart rate increased; couldn't sleep the night; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart Palpitations), HEART RATE INCREASED (Heart rate increased) and INSOMNIA (couldn't sleep the night) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 11-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Apr-2021, the patient experienced PALPITATIONS (Heart Palpitations), HEART RATE INCREASED (Heart rate increased) and INSOMNIA (couldn't sleep the night). At the time of the report, PALPITATIONS (Heart Palpitations), HEART RATE INCREASED (Heart rate increased) and INSOMNIA (couldn't sleep the night) outcome was unknown.            Concomitant medications included birth control, vitamins and supplements.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: same numbness but no discoloration; This spontaneous case was reported by a health care professional and describes the occurrence of HYPOAESTHESIA (same numbness but no discoloration) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported by the reporter.     On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPOAESTHESIA (same numbness but no discoloration). At the time of the report, HYPOAESTHESIA (same numbness but no discoloration) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-077916 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077916:CROSSLINKED WITH DOSE 2
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: (hives)eventually grew; a few Hives; itching on her body, feet, eyes, and lips; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (a few Hives), URTICARIA ((hives)eventually grew) and PRURITUS (itching on her body, feet, eyes, and lips) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced URTICARIA (a few Hives). On an unknown date, the patient experienced URTICARIA ((hives)eventually grew) and PRURITUS (itching on her body, feet, eyes, and lips). At the time of the report, URTICARIA (a few Hives) and URTICARIA ((hives)eventually grew) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Peripheral swelling
Clinical narrative: swollen arm; was feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swollen arm) and FATIGUE (was feeling tired) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (swollen arm) and FATIGUE (was feeling tired). At the time of the report, PERIPHERAL SWELLING (swollen arm) and FATIGUE (was feeling tired) had resolved. Not Provided          No concomitant medication was reported.  Patient experienced events after second dose. Events lasted only two days and she was fine at the time of reporting.  No treatment medication was reported.  Action taken with mRNA-1273 with respect to events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Follow-up information received on 18-May-2021 contain no new information.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Feeding disorder, Hyperhidrosis
Clinical narrative: diarrhea; hot sweats; dizziness; Was very very sick and almost to call 911".; couldn't eat any thing because of constant throwing up; did not sleep on those 2 nights; throwing up; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), HYPERHIDROSIS (hot sweats), DIZZINESS (dizziness), ILLNESS (Was very very sick and almost to call 911".) and FEEDING DISORDER (couldn't eat any thing because of constant throwing up) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol. Concomitant products included VITAMIN D NOS for an unknown indication.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced DIARRHOEA (diarrhea), HYPERHIDROSIS (hot sweats), DIZZINESS (dizziness), ILLNESS (Was very very sick and almost to call 911".), FEEDING DISORDER (couldn't eat any thing because of constant throwing up), INSOMNIA (did not sleep on those 2 nights), VOMITING (throwing up) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Apr-2021, INSOMNIA (did not sleep on those 2 nights) had resolved. At the time of the report, DIARRHOEA (diarrhea), HYPERHIDROSIS (hot sweats), DIZZINESS (dizziness), ILLNESS (Was very very sick and almost to call 911".), FEEDING DISORDER (couldn't eat any thing because of constant throwing up), VOMITING (throwing up) and CHILLS (chills) outcome was unknown. Not Provided          Other Concomitant products included Cholesterol medication for an unknown indication. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Insomnia, Vomiting
Clinical narrative: diarrhea; hot sweats; dizziness; Was very very sick and almost to call 911".; couldn't eat any thing because of constant throwing up; did not sleep on those 2 nights; throwing up; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), HYPERHIDROSIS (hot sweats), DIZZINESS (dizziness), ILLNESS (Was very very sick and almost to call 911".) and FEEDING DISORDER (couldn't eat any thing because of constant throwing up) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol. Concomitant products included VITAMIN D NOS for an unknown indication.   On 10-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced DIARRHOEA (diarrhea), HYPERHIDROSIS (hot sweats), DIZZINESS (dizziness), ILLNESS (Was very very sick and almost to call 911".), FEEDING DISORDER (couldn't eat any thing because of constant throwing up), INSOMNIA (did not sleep on those 2 nights), VOMITING (throwing up) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 11-Apr-2021, INSOMNIA (did not sleep on those 2 nights) had resolved. At the time of the report, DIARRHOEA (diarrhea), HYPERHIDROSIS (hot sweats), DIZZINESS (dizziness), ILLNESS (Was very very sick and almost to call 911".), FEEDING DISORDER (couldn't eat any thing because of constant throwing up), VOMITING (throwing up) and CHILLS (chills) outcome was unknown. Not Provided          Other Concomitant products included Cholesterol medication for an unknown indication. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: some symptoms right after the first dose and they got worse after the second one: continuous itching on the back of his shoulders, down his spine, on his upper chest, center of his forehead and cheeks. It doesn't look irritated, but feels irritated,; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (some symptoms right after the first dose and they got worse after the second one: continuous itching on the back of his shoulders, down his spine, on his upper chest, center of his forehead and cheeks. It doesn't look irritated, but feels irritated,) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 026A21A) for COVID-19 vaccination.     no medical history information was history.  Concomitant products included AMLODIPINE for an unknown indication.   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (some symptoms right after the first dose and they got worse after the second one: continuous itching on the back of his shoulders, down his spine, on his upper chest, center of his forehead and cheeks. It doesn't look irritated, but feels irritated,). The patient was treated with CORTISONE (topical) for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (some symptoms right after the first dose and they got worse after the second one: continuous itching on the back of his shoulders, down his spine, on his upper chest, center of his forehead and cheeks. It doesn't look irritated, but feels irritated,) had not resolved.            The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the events is not applicable.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain
Clinical narrative: achy; my ark is kind of sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (achy) and MYALGIA (my ark is kind of sore) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     Concomitant products included TAMSULOSIN HYDROCHLORIDE (FLOMAX [TAMSULOSIN HYDROCHLORIDE]) for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (achy) and MYALGIA (my ark is kind of sore). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (achy) and MYALGIA (my ark is kind of sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD21-076273, MOD21-076422 (E2B Linked Report).; Sender's Comments:  MOD21-076273:Wife MOD21-076422:
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity
Clinical narrative: aches and pains; arm hurting; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills), PAIN (aches and pains), HEADACHE (headache) and PAIN IN EXTREMITY (arm hurting) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 15-Apr-2021, the patient experienced CHILLS (chills), PAIN (aches and pains), HEADACHE (headache) and PAIN IN EXTREMITY (arm hurting). At the time of the report, CHILLS (chills), PAIN (aches and pains), HEADACHE (headache) and PAIN IN EXTREMITY (arm hurting) outcome was unknown.            Reporter did not allow further contact
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchy rash from injection site to below the site; dark red itchy rash from injection site to below the site; dark red rash from injection site to below the site; arm was a little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was a little sore), VACCINATION SITE PRURITUS (itchy rash from injection site to below the site), VACCINATION SITE RASH (dark red itchy rash from injection site to below the site) and VACCINATION SITE ERYTHEMA (dark red rash from injection site to below the site) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm was a little sore). On 10-Apr-2021, the patient experienced VACCINATION SITE RASH (dark red itchy rash from injection site to below the site) and VACCINATION SITE ERYTHEMA (dark red rash from injection site to below the site). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy rash from injection site to below the site). On 06-Apr-2021, PAIN IN EXTREMITY (arm was a little sore) had resolved. At the time of the report, VACCINATION SITE PRURITUS (itchy rash from injection site to below the site), VACCINATION SITE RASH (dark red itchy rash from injection site to below the site) and VACCINATION SITE ERYTHEMA (dark red rash from injection site to below the site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was unknown. Treatment Benadryl and BioCatalase liposomal gluten free cream.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Outcome information
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17 yr old patient received first dose; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 yr old patient received first dose) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 yr old patient received first dose). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17 yr old patient received first dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Hypersensitivity, Pruritus
Clinical narrative: Dermal Hypersensitivity on the trunk; Intense burning; Intense itching; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 15-Apr-2021 and was forwarded to Moderna on 15-Apr-2021.    This spontaneous case was reported by a health care professional and describes the occurrence of HYPERSENSITIVITY (Dermal Hypersensitivity on the trunk), BURNING SENSATION (Intense burning) and PRURITUS (Intense itching) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), FEXOFENADINE HYDROCHLORIDE (ALLEGRA), BUSPIRONE, LEVOTHYROXINE, OMEPRAZOLE, FLUOXETINE, TAMSULOSIN and CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) for an unknown indication.    On 30-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Dermal Hypersensitivity on the trunk), BURNING SENSATION (Intense burning) and PRURITUS (Intense itching). At the time of the report, HYPERSENSITIVITY (Dermal Hypersensitivity on the trunk), BURNING SENSATION (Intense burning) and PRURITUS (Intense itching) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Skin discolouration
Clinical narrative: feeling numbness on the left hand and the fingers have turn white and now the same thing is; feeling numbness on the left hand and the fingers have turn white and now the same thing is; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (feeling numbness on the left hand and the fingers have turn white and now the same thing is) and SKIN DISCOLOURATION (feeling numbness on the left hand and the fingers have turn white and now the same thing is) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 14-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced HYPOAESTHESIA (feeling numbness on the left hand and the fingers have turn white and now the same thing is) and SKIN DISCOLOURATION (feeling numbness on the left hand and the fingers have turn white and now the same thing is). At the time of the report, HYPOAESTHESIA (feeling numbness on the left hand and the fingers have turn white and now the same thing is) and SKIN DISCOLOURATION (feeling numbness on the left hand and the fingers have turn white and now the same thing is) outcome was unknown.            On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-077898 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-077898:CROSSLINKED WITH DOSE 1
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Lymph node pain, Lymphadenopathy
Clinical narrative: sore throat; lymph node are painful and swollen; awful headache; lymph node are painful and swollen; not feel great; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feel great), OROPHARYNGEAL PAIN (sore throat), LYMPH NODE PAIN (lymph node are painful and swollen), CHILLS (chills) and HEADACHE (awful headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced CHILLS (chills). On 12-Apr-2021, the patient experienced FEELING ABNORMAL (not feel great). On 13-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), LYMPH NODE PAIN (lymph node are painful and swollen), HEADACHE (awful headache) and LYMPHADENOPATHY (lymph node are painful and swollen). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. On 10-Apr-2021, CHILLS (chills) had resolved. At the time of the report, FEELING ABNORMAL (not feel great) outcome was unknown and OROPHARYNGEAL PAIN (sore throat), LYMPH NODE PAIN (lymph node are painful and swollen), HEADACHE (awful headache) and LYMPHADENOPATHY (lymph node are painful and swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat; lymph node are painful and swollen; awful headache; lymph node are painful and swollen; not feel great; chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feel great), OROPHARYNGEAL PAIN (sore throat), LYMPH NODE PAIN (lymph node are painful and swollen), CHILLS (chills) and HEADACHE (awful headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Apr-2021, the patient experienced CHILLS (chills). On 12-Apr-2021, the patient experienced FEELING ABNORMAL (not feel great). On 13-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat), LYMPH NODE PAIN (lymph node are painful and swollen), HEADACHE (awful headache) and LYMPHADENOPATHY (lymph node are painful and swollen). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 1 dosage form. On 10-Apr-2021, CHILLS (chills) had resolved. At the time of the report, FEELING ABNORMAL (not feel great) outcome was unknown and OROPHARYNGEAL PAIN (sore throat), LYMPH NODE PAIN (lymph node are painful and swollen), HEADACHE (awful headache) and LYMPHADENOPATHY (lymph node are painful and swollen) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Prenatal screening test, Ultrasound ovary
Clinical narrative: first Moderna Covid-19 dose received while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (first Moderna Covid-19 dose received while pregnant) in a 35-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included No adverse event. Concomitant products included VITAMINS NOS (MULTIVITAMINUM) from 25-Feb-2021 to an unknown date, COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX) from 25-Feb-2021 to an unknown date and FISH OIL (FISH OIL NATURE MADE) from 25-Feb-2021 to an unknown date for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 23-Dec-2020 and the estimated date of delivery was 07-Oct-2021. On 15-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (first Moderna Covid-19 dose received while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  sixteenth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (first Moderna Covid-19 dose received while pregnant) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Prenatal screening test: 26-mar-2021 (normal) no genetic defects, foetus male gender. On 26-Mar-2021, Ultrasound ovary: hz (normal) ovarian cyst on left ovary noted.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.